Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved..
Dengue hemorrhagic fever (DHF) is a severe condition resulting from the dengue virus, with four serotypes known as DEN-1, DEN-2, DEN-3, and DEN-4. Genetic variations play a crucial role in influencing susceptibility to DHF. Therefore, this investigation conducted a meta-analysis to uncover genetic changes that might have remained undetected in individual studies due to small sample sizes or methodological differences. Among 2212 initially identified studies, 23 were deemed suitable for analysis based on PRISMA guidelines. Toll-like receptors (TLR) and CD209 showed significant association with DHF (odds ratios: TLR=0.56, CD209 =0.55), indicating protective effects. However, tumor necrosis factor (TNF) and human leukocyte antigen (HLA) did not exhibit a statistically significant relationship with DHF. This study emphasizes the relevance of TLR and CD209 in DHF susceptibility and resistance across diverse geographical locations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
---|---|
Enthalten in: |
Journal of infection and public health - 17(2024), 4 vom: 22. März, Seite 579-587 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kanan, Mohammed [VerfasserIn] |
---|
Links: |
---|
Themen: |
Dengue virus |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jiph.2024.02.001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36858707X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36858707X | ||
003 | DE-627 | ||
005 | 20240325234902.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240219s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jiph.2024.02.001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1346.xml |
035 | |a (DE-627)NLM36858707X | ||
035 | |a (NLM)38368646 | ||
035 | |a (PII)S1876-0341(24)00027-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kanan, Mohammed |e verfasserin |4 aut | |
245 | 1 | 0 | |a Genetic variants associated with dengue hemorrhagic fever. A systematic review and meta-analysis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a Dengue hemorrhagic fever (DHF) is a severe condition resulting from the dengue virus, with four serotypes known as DEN-1, DEN-2, DEN-3, and DEN-4. Genetic variations play a crucial role in influencing susceptibility to DHF. Therefore, this investigation conducted a meta-analysis to uncover genetic changes that might have remained undetected in individual studies due to small sample sizes or methodological differences. Among 2212 initially identified studies, 23 were deemed suitable for analysis based on PRISMA guidelines. Toll-like receptors (TLR) and CD209 showed significant association with DHF (odds ratios: TLR=0.56, CD209 =0.55), indicating protective effects. However, tumor necrosis factor (TNF) and human leukocyte antigen (HLA) did not exhibit a statistically significant relationship with DHF. This study emphasizes the relevance of TLR and CD209 in DHF susceptibility and resistance across diverse geographical locations | ||
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Dengue virus | |
650 | 4 | |a Human leukocyte antigen | |
650 | 4 | |a Meta-analysis | |
650 | 4 | |a Odd ratio | |
650 | 4 | |a TNF toll-like receptors | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
700 | 1 | |a Naffaa, Mohammed |e verfasserin |4 aut | |
700 | 1 | |a Alanazi, Ahmed |e verfasserin |4 aut | |
700 | 1 | |a Nasser, Faiz |e verfasserin |4 aut | |
700 | 1 | |a Alsaiari, Ahad Amer |e verfasserin |4 aut | |
700 | 1 | |a Almehmadi, Mazen |e verfasserin |4 aut | |
700 | 1 | |a Assiry, Ali |e verfasserin |4 aut | |
700 | 1 | |a Muzafar, Hisham |e verfasserin |4 aut | |
700 | 1 | |a Katam, Hejab |e verfasserin |4 aut | |
700 | 1 | |a Arar, Abdullah |e verfasserin |4 aut | |
700 | 1 | |a Asdaq, Syed Mohammed Basheeruddin |e verfasserin |4 aut | |
700 | 1 | |a Abida |e verfasserin |4 aut | |
700 | 1 | |a Imran, Mohd |e verfasserin |4 aut | |
700 | 1 | |a Dzinamarira, Tafadzwa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of infection and public health |d 2008 |g 17(2024), 4 vom: 22. März, Seite 579-587 |w (DE-627)NLM200240730 |x 1876-035X |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2024 |g number:4 |g day:22 |g month:03 |g pages:579-587 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jiph.2024.02.001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 17 |j 2024 |e 4 |b 22 |c 03 |h 579-587 |